NEW Product

Recombinant Human FGF-basic

Waisman Biomanufacturing sells human FGF-basic produced under cGMP conditions for use in culturing stem cells for human clinical trials or in research applications that are anticipated to lead to clinical research.
Read more

In the News

Stratatech Initiates Second Clinical Trial of StrataGraft Skin Substitute.

Waisman Biomanufacturing has been working with Stratatech since 2005 in an ongoing effort to provide cGMP grade material for their clinical trials. To date, more than 100 batch lots of StrataGraft skin substitute have been manufactured in our facility. We are proud to be a part of their success as they enter into a second multicenter clinical trial to assess safety and clinical utility of StrataGraft skin substitute in the long term treatment of second degree burn patients.
Read more

In the News

Stratatech Initiates Second Clinical Trial of StrataGraft® Skin Substitute

Waisman Biomanufacturing has been working with Stratatech since 2005 in an ongoing effort to provide cGMP grade material for their clinical trials. To date, more than 100 batch lots of StrataGraft® skin substitute have been manufactured in our facility. We are proud to be a part of their success as they enter into a second multicenter clinical trial to assess safety and clinical utility of StrataGraft® skin substitute in the long term treatment of second degree burn patients.
Read more

In The News

Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial

Waisman Biomanufacturing has been working with Aduro Biotech and its predecessors since 2005 in an ongoing effort to provide cGMP grade live, whole-cell therapeutics for their clinical trials. To date materials for use in preclinical studies as well as Phase1 and Phase 2 trials have been manufactured in our facility. We are proud to be a part of their success as they enter into Phase 2 clinical trials to assess efficacy and immune response of CRS-207 in pancreatic cancer patients.
Read more

In the News

Stratatech Skin Substitute Success

Waisman Biomanufacturing has been partnered with Stratatech since 2005 in an ongoing effort to provide cGMP grade material for their clinical trials. To date, more than 100 batch lots of StrataGraft® skin substitute have been manufactured in our facility. WB is proud to be a part of Stratatech's success as they move forward in their novel treatment of severe burns.
Read more

Upcoming Event

Oct

21

8th Annual Wisconsin Stem Cell Symposium

April 10, 2013 Cell-Based Therapy for Heart and Vascular Disease: Pathways to Clinic BioPharmaceutical Technology Center Institute (BTCI) 5445 Cheryl Pkwy Madison, WI
Read more

Upcoming Event

Oct

21

PACT Webinar

PACT Webinar: Cell Therapy for Lung Indications February 20, 2013
Read more

Upcoming Event

Oct

21

ASGCT 16th Annual Meeting

Waisman Biomanufacturing will be attending! May 15 – 18, 2013 Salt Lake City, Utah Booth Number TBD
Read more

What's New at Waisman Biomanufacturing

Highlights

Here at Waisman Biomanufacturing, we have a focus on building strong client relationships and work hard to provide a positive working experience. See what Waisman Biomanufacturing is doing...
Read more